Hint mode is switched on Switch off
For swift navigation between sections

Organization: Nevro
LEI 254900SH91I4BOYKUE38

Organization name
Nevro Corp.
Country name
USA
Country of registration
USA
Industry
Medical Devices
Bond debt
165 mln USD

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain in the United States, Europe, and Australia. It offers Senza system, a spinal cord stimulation system that delivers its proprietary HF10 therapy. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

Awards

News

21/02/2024 Nevro: Entry Into A Material Definitive Agreement, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
21/02/2024 Nevro: Results Of Operations And Financial Condition, Financial Statements And Exhibits
06/01/2024 Nevro: Results Of Operations And Financial Condition, Costs Associated With Exit Or Disposal Activities, Financial Statements And Exhibits
30/11/2023 Nevro: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Creation Of A Direct Financial Obligation Or An Obligation Under An, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits
01/11/2023 Nevro: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    254900SH91I4BOYKUE38
  • SIC
    3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • CIK
    0001444380
  • EIN
    56-2568057

Credit and ESG Ratings

Macroeconomic Indicators - Nevro

Registration is required to get access.